PLOS ONE 润色咨询

PLoS One

出版年份：2006 年文章数：239709 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：6.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2024-03-05 ms1000000466115089 来自四川省

    请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2023-08-11 浩浩Peter 来自内蒙古

    decision in process过程一般需要多久

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2023-08-16 认认真真发文章 来自广东省

    外审一个半月了，还没有结果，请问大家外审多久？好急啊

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2023-05-04 ms5000000466635690 来自山东省

    under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2023-07-05 ms1000002053651014 来自山东省

    大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2022-09-29 ms8000001469731860

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2022-10-11 1e18c142m55(暂无匿称)

    投稿命中率:95.0
    经验分享：呵呵

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2022-12-28 ms5000001749363535 来自江苏省

    投稿命中率:95.0
    经验分享：挺容易的

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2023-02-02 ms1000001611299935 来自广东省

    审稿速度:2.0 | 投稿命中率:5.0
    偏重的研究方向：基础医学
    经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand.

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2191124, encodeId=e3b82191124fc, content=请问各位老师文章online 后是多久可以在web of science 里面查询被SCI收录的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eef85453005, createdName=ms1000000466115089, createdTime=Tue Mar 05 10:27:18 CST 2024, time=2024-03-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2152218, encodeId=972f2152218c9, content=decision in process过程一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Fri Aug 11 08:33:43 CST 2023, time=2023-08-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2153074, encodeId=cf6621530e4f8, content=外审一个半月了，还没有结果，请问大家外审多久？好急啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adec8342676, createdName=认认真真发文章, createdTime=Wed Aug 16 19:06:26 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130049, encodeId=a8d62130049b3, content=under review快两个月了，不是说一个月就差不多了吗，最近很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ca28283274, createdName=ms5000000466635690, createdTime=Thu May 04 14:24:43 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146478, encodeId=7ec221464e8aa, content=大修后under review要多久，20天了完全没消息，decision inprocess会有邮箱通知么<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0cd78450997, createdName=ms1000002053651014, createdTime=Wed Jul 05 16:39:12 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091083, encodeId=e6e52091083b5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：通讯填的邮箱在手稿提交后注册plos one，再用邮箱号登录怎么看不到提交的稿件呢，找不到稿件了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e06561243, createdName=ms8000001469731860, createdTime=Thu Sep 29 20:57:47 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093084, encodeId=71712093084ee, content=投稿命中率:95.0<br>经验分享：呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3371983863, createdName=1e18c142m55(暂无匿称), createdTime=Tue Oct 11 10:31:17 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107892, encodeId=ee3e210e8927a, content=投稿命中率:95.0<br>经验分享：挺容易的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c8463060, createdName=ms5000001749363535, createdTime=Wed Dec 28 20:17:44 CST 2022, time=2022-12-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2112676, encodeId=6c8221126e6fa, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：基础医学<br>经验分享：自认倒霉了遇到韩国人做我的学术编辑，这篇文章感觉要黄了，这个学术编辑另附加了一个回复As academic editor of your manuscript, I have to mention the followings: 1. The decoction is crude extracts-based and therefore, each compound should be explained in separate Tables with appropriate references. 2. The Plos one persues the original and mechanism certainty studies. In this meaning, we can recommend your revision to submit to more specialized jornals such as ethnopharmacology or ethnomedicine, as you agree with. Therefore, your revision is not guaranted to accept, as you would understand. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e925457326, createdName=ms1000001611299935, createdTime=Thu Feb 02 03:15:42 CST 2023, time=2023-02-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115078, encodeId=3fe221150e8ef, content=请问这个杂志接收综述吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1a18229808, createdName=ms7000001025891884, createdTime=Fri Feb 17 12:12:54 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省)]
    2023-02-17 ms7000001025891884 来自河南省

    请问这个杂志接收综述吗

    1

    展开1条回复
共500条页码: 12/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分